.

Deeper Knowledge, Faster

  • Analyze global market entry opportunities
  • Uncover prior art in expired and abandoned patents
  • Obtain formulation and manufacturing information

► See Plans and Pricing

Upgrade to enjoy subscriber-only features like email alerts and data export. See the Plans and Pricing

Serving 500+ biopharmaceutical companies globally:

Dow
Cantor Fitzgerald
Queensland Health
US Department of Justice
Cipla
Harvard Business School
Farmers Insurance
AstraZeneca
QuintilesIMS
Chinese Patent Office

Generated: June 23, 2017

DrugPatentWatch Database Preview

Details for New Drug Application (NDA): 086925

« Back to Dashboard
NDA 086925 describes ISOSORBIDE DINITRATE, which is a drug marketed by Sun Pharm Inds, Sun Pharm Inds Inc, Sandoz, Impax Labs Inc, Par Pharm, Watson Labs Teva, Watson Labs, Hikma Intl Pharms, and Superpharm, and is included in thirty-one NDAs. It is available from twenty-four suppliers. Additional details are available on the ISOSORBIDE DINITRATE profile page.

The generic ingredient in ISOSORBIDE DINITRATE is isosorbide dinitrate. There are thirty-seven drug master file entries for this compound. Twenty-six suppliers are listed for this compound. Additional details are available on the isosorbide dinitrate profile page.

Summary for NDA: 086925

Tradename:
1
Applicant:
1
Ingredient:
1
Patents:1
Therapeutic Class:Cardiovascular Agents
Formulation / Manufacturing:see details

Pharmacology for NDA: 086925

Ingredient-typeNitrates
Physiological EffectVasodilation

Suppliers and Packaging for NDA: 086925

Tradename Generic Name Dosage NDA Application Type Supplier National Drug Code Package Code Package
ISOSORBIDE DINITRATE
isosorbide dinitrate
TABLET;ORAL 086925 ANDA Aphena Pharma Solutions - Tennessee, LLC 43353-139 43353-139-60 90 TABLET in 1 BOTTLE (43353-139-60)
ISOSORBIDE DINITRATE
isosorbide dinitrate
TABLET;ORAL 086925 ANDA Par Pharmaceutical Inc. 49884-021 49884-021-01 100 TABLET in 1 BOTTLE (49884-021-01)

Summary for product number 001

Active Rx/OTC/Discontinued:RXDosage:TABLET;ORALStrength10MG
Approval Date:Mar 12, 1987TE:ABRLD:No


Complete Access Available with Subscription
« Back to Dashboard

For more information try a trial or see the database preview and plans and pricing

Serving 500+ biopharmaceutical companies globally:

Julphar
Healthtrust
Covington
QuintilesIMS
Chinese Patent Office
Chubb
Daiichi Sankyo
Moodys
Cantor Fitzgerald
Teva

Drugs may be covered by multiple patents or regulatory protections. All trademarks and applicant names are the property of their respective owners or licensors. Although great care is taken in the proper and correct provision of this service, thinkBiotech LLC does not accept any responsibility for possible consequences of errors or omissions in the provided data. The data presented herein is for information purposes only. There is no warranty that the data contained herein is error free. thinkBiotech performs no independent verifification of facts as provided by public sources nor are attempts made to provide legal or investing advice. Any reliance on data provided herein is done solely at the discretion of the user. Users of this service are advised to seek professional advice and independent confirmation before considering acting on any of the provided information. thinkBiotech LLC reserves the right to amend, extend or withdraw any part or all of the offered service without notice.

Copyright 2002-2017 thinkBiotech LLC
ISSN: 2162-2639

Secure SSL Encrypted

Follow DrugPatentWatch:



Google
Twitter
Google Plus
botpot